Idursulfase

3 trials 2 recruiting AGastroenterology Orphan designation

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

3 Sponsors

9 Countries

Phase III

Phase II/III

Phase III: 2 Phase II/III: 1

Indications tested

Mucopolysaccharidosis II 1

Sponsors using this IMP

Denali Therapeutics Inc. 1 Jcr Pharmaceuticals Co. Ltd. 1 Takeda Development Center Americas Inc. 1

All trials

3 total

An Open-Label Extension for Subjects in Studies HGT-HIT-046 and SHP609-302 Evaluating Long-Term Safety of Intrathecal Idursulfase-IT Adminis… Recruiting

2023-504127-90-00 Phase III 1 country Takeda Development Center Americas Inc.
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neu… Recruiting

2024-510990-21-00 Phase II/III 8 countries Denali Therapeutics Inc.
A study to evaluate the efficacy and safety of treatment with JR-141 Ended

2024-512289-33-00 Phase III 5 countries Jcr Pharmaceuticals Co. Ltd.

Showing 1–3 of 3 trials

← All drugs A–Z